Cargando…

Analysis of VEGFA Variants and Changes in VEGF Levels Underscores the Contribution of VEGF to Polycystic Ovary Syndrome

BACKGROUND: Vascular endothelial growth factor (VEGF) contributes to the pathogenesis of polycystic ovary syndrome (PCOS), and genetic variations in VEGFA gene were suggested to contribute to VEGF secretion and PCOS. AIM: To evaluate the association of altered VEGF levels, stemming from the presence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almawi, Wassim Y, Gammoh, Emily, Malalla, Zainab H., Al-Madhi, Safa A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112863/ https://www.ncbi.nlm.nih.gov/pubmed/27846231 http://dx.doi.org/10.1371/journal.pone.0165636

Ejemplares similares

MON-234 Targeted Profiling of Plasma MicroRNAs in Women with Polycystic Ovary Syndrome (PCOS): Impact of Obesity
por: Almawi, Wassim, et al.
Publicado: (2019)

Polymorphisms rs2010963 and rs833061 of the VEGF gene in polycystic ovary syndrome
por: Vicente, Anna Luiza Silva Almeida, et al.
Publicado: (2022)

VEGFA Haplotype and VEGF-A and VEGF-R2 Protein Associations with Exudative Age-Related Macular Degeneration
por: Vilkeviciute, Alvita, et al.
Publicado: (2022)

Association between VEGF gene polymorphisms (11 sites) and polycystic ovary syndrome risk
por: Huang, Li, et al.
Publicado: (2020)

The Regulators of VEGF Expression in Mouse Ovaries
por: Shin, So-Young, et al.
Publicado: (2005)

Non-proteolytic calpain-6 interacts with VEGFA and promotes angiogenesis by increasing VEGF secretion
por: Oh, Mijung, et al.
Publicado: (2019)

Elevated VEGF levels contribute to the pathogenesis of osteoarthritis
por: Yuan, Quan, et al.
Publicado: (2014)

Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case–control study of women from Bahraini medical clinics
por: Kalyan, Shirin, et al.
Publicado: (2018)

Proangiogenic Interactions of Vascular Endothelial MMP14 With VEGF Receptor 1 in VEGFA-Mediated Corneal Angiogenesis
por: Han, Kyu-Yeon, et al.
Publicado: (2016)

Contrasting association of Leptin receptor polymorphisms and haplotypes with polycystic ovary syndrome in Bahraini and Tunisian women: a case–control study
por: Dallel, Meriem, et al.
Publicado: (2021)

Vascular endothelial growth factor (VEGFA) gene variation in polycystic ovary syndrome in a Tunisian women population
por: Ben Salem, Assila, et al.
Publicado: (2016)

MiR-185-5p Protects Against Angiogenesis in Polycystic Ovary Syndrome by Targeting VEGFA
por: Wei, Jingzan, et al.
Publicado: (2020)

Histomorphological Changes in a Rat Model of Polycystic Ovary Syndrome and the Contribution of Stevia Leaf Extract in Modulating the Ovarian Fibrosis, VEGF, and TGF-β Immunoexpressions: Comparison with Metformin
por: Morsi, Ahmed A., et al.
Publicado: (2022)

Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Müller cells maintains retinal function by triggering different signaling mechanisms
por: Becker, Silke, et al.
Publicado: (2018)

N-VEGF, the Autoregulatory Arm of VEGF-A
por: Katsman, Marina, et al.
Publicado: (2022)

VEGF(121)b and VEGF(165)b are weakly angiogenic isoforms of VEGF-A
por: Catena, Raúl, et al.
Publicado: (2010)

CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance
por: Ma, Shaolin, et al.
Publicado: (2021)

The blunted vascular endothelial growth factor-A (VEGF-A) response to high-altitude hypoxia and genetic variants in the promoter region of the VEGFA gene in Sherpa highlanders
por: Droma, Yunden, et al.
Publicado: (2022)

Does VEGF-targeted active immunotherapy induce complete abrogation of platelet VEGF levels?
por: Sánchez Ramírez, Javier, et al.
Publicado: (2019)

What Is the Contribution of Two Genetic Variants Regulating VEGF Levels to Type 2 Diabetes Risk and to Microvascular Complications?
por: Bonnefond, Amélie, et al.
Publicado: (2013)

Autonomic dysfunction in women with polycystic ovary syndrome
por: Hashim, Zainab Hasan, et al.
Publicado: (2015)

The Presence of VEGF Receptors on the Luminal Surface of Endothelial Cells Affects VEGF Distribution and VEGF Signaling
por: Stefanini, Marianne O., et al.
Publicado: (2009)

Relationship between VEGF Gene Polymorphisms and Serum VEGF Protein Levels in Patients with Rheumatoid Arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2016)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

VEGF, VEGF165b and EG-VEGF expression is specifically related with hormone profile in pituitary adenomas
por: Corlan, Ana Silvia, et al.
Publicado: (2019)

Proteolytic Cleavages in the VEGF Family: Generating Diversity among Angiogenic VEGFs, Essential for the Activation of Lymphangiogenic VEGFs
por: Künnapuu, Jaana, et al.
Publicado: (2021)

ERK5 Contributes to VEGF Alteration in Diabetic Retinopathy
por: Wu, Yuexiu, et al.
Publicado: (2010)

Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug
por: Stewart, Michael W
Publicado: (2012)

Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy
por: Parveen, Amna, et al.
Publicado: (2019)

Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer
por: Zajkowska, Monika, et al.
Publicado: (2018)

Cutaneous manifestation of polycystic ovary syndrome
por: Abusailik, Mohammad A., et al.
Publicado: (2021)

Alterations of IL-1 and VEGF After Ischemia-Reperfusion Injured Uterus and Ovary in Rats
por: Ersoy Canillioglu, Yasemin, et al.
Publicado: (2020)

Platelets and VEGF blood levels in cancer patients
por: Gunsilius, E, et al.
Publicado: (1999)

Binding of VEGF-A is sufficient to abrogate the disturbing effects of VEGF-B together with VEGF-A on retinal endothelial cells
por: Deissler, Heidrun L., et al.
Publicado: (2015)

Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma
por: Pritchard-Jones, R O, et al.
Publicado: (2007)

Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer
por: Kut, C, et al.
Publicado: (2007)

Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D
por: McColl, Bradley K., et al.
Publicado: (2003)

Computational Modeling of Interacting VEGF and Soluble VEGF Receptor Concentration Gradients
por: Hashambhoy, Yasmin L., et al.
Publicado: (2011)

VEGF Spliced Variants: Possible Role of Anti-Angiogenesis Therapy
por: Hilmi, Caroline, et al.
Publicado: (2012)

VEGF-A splice variants bind VEGFRs with differential affinities
por: Mamer, Spencer B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_58mr82mhmusoq0ucv6lg6um5te